Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

2.73
+0.01000.37%
Volume:46.73K
Turnover:129.18K
Market Cap:87.89M
PE:-6.94
High:2.80
Open:2.79
Low:2.72
Close:2.72
Loading ...
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 10, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 10, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 16, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Major Issues Report

8-K - Current report
Mar 17, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 10, 2023

Major Issues Report

8-K - Current report